KabaFusion and CareCloud Partner to Build AI-Powered Home Infusion Platform
Event summary
- KabaFusion, a large home infusion therapy provider, partners with CareCloud to develop LailaCare, an AI-powered platform for home infusion workflows.
- LailaCare will integrate referral intake, eligibility and authorization, patient engagement, and revenue cycle management into a single platform.
- CareCloud will design and develop the platform, which will be owned by KabaFusion.
- The platform aims to reduce administrative burden and accelerate patient onboarding.
- AI will power end-to-end workflows, including referral routing, eligibility support, and claims scrubbing.
The big picture
This partnership underscores the growing trend of AI integration in healthcare technology, aiming to streamline operations and improve patient care. CareCloud's 25-year history in building healthcare platforms at scale, combined with KabaFusion's deep operational expertise, positions LailaCare as a potential industry standard. The collaboration highlights the strategic shift towards leveraging AI to reduce administrative burdens and enhance the patient experience in home infusion therapy.
What we're watching
- Integration Success
- How CareCloud's AI capabilities will integrate with KabaFusion's operational expertise to deliver measurable value.
- Market Expansion
- Whether the platform will position KabaFusion for further growth in the home infusion and specialty pharmacy markets.
- AI Adoption
- The pace at which AI-driven solutions will become standard in home infusion and specialty pharmacy operations.
Related topics